Director/PDMR Shareholding

RNS Number : 1453I
Burberry Group PLC
06 August 2019
 

Burberry Group plc (the "Company") - Director/PDMR Shareholding

 

The Company announces that it received notification on 6 August 2019 that following the Final Dividend payment on 2 August 2019, Equiniti purchased Ordinary Shares of 0.05 pence each in the Company ("Shares") on 5 August 2019 for the following Director under a Dividend Reinvestment Plan at a price of 2172.45 pence per Share.

 

 

Director

Number of Shares purchased

Julie Brown

1,524

 

6 August 2019

 

The following disclosures are made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.

Notification of dealing form

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Julie Brown

2

Reason for the notification

a)

Position/status

Chief Operating and Financial Officer

 

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Burberry Group plc

b)

LEI

213800PE1KEFCNFR1R50

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.05 pence each

 

 

GB0031743007

b)

Nature of the transaction

Purchase of ordinary shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£21.7245

 

1,524

 

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Aggregate Price

Aggregate Volume

Aggregate

Total

£21.7245

 

1,524

£33,108.14

 

e)

Date of the transaction

2019-08-05

 

f)

Place of the transaction

XLON

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLLFFETAIRIIA
UK 100

Latest directors dealings